| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |